Chugai Pharma USA LLC is a research-based, global pharmaceutical company that discovers and develops innovative therapeutic products treating cardiovascular diseases and cancer.
Chugai Pharma USA LLC is a research-based, global pharmaceutical company that discovers and develops innovative therapeutic products treating cardiovascular diseases and cancer.
Chugai Pharmaceutical Co., Ltd. Web Site ... 06/16/2008 Data from Overseas Phase III Trial (RADIATE and AMBITION) Demonstrates Efficacy of "Actemra ® ...
Chugai Pharmaceutical Co., Ltd. (hereafter Chugai Pharmaceutical), as a company that impacts human life, conforms to the highest ethical and moral standards, has the primary focus ...
April 22 (Reuters) - CHUGAI PHARMACEUTICAL CO LTD CONSOLIDATED EARNINGS ESTIMATES (in billions of yen unless specified) Full year to Full year to Full year ended Dec 31,2008 Dec 31 ...
April 22 (Reuters) - CHUGAI PHARMACEUTICAL CO LTD CONSOLIDATED EARNINGS ESTIMATES (in billions of yen unless specified) 6 months to 6 months to 6 months ended June 30,2008 June 30 ...
Get stocks charts, indexes charts. Add moving averages, indexes, splits, dividends and more to complete your analysis.
Chugai Pharm Ord Shs (CHGCF) Advisor FYI Alerts let you know when significant events have occurred that may affect your stock investments.
MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products. ...
Updates to midsession) TOKYO, Oct 24 (Reuters) - Japan's Nikkei average rose 0.8 percent on Wednesday following gains on Wall Street, with Chugai Pharmaceutical Co Ltd
Adds stocks and comments) By Taiga Uranaka TOKYO, Oct 24 (Reuters) - The Nikkei average rose 0.8 percent on Wednesday following gains on Wall Street, but the market looked ...
Get detailed information on CHUGAI PHARM (CUP.F) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
Yuji Kimura Clinical-trials@chugai-pharm.co.jp : Tohoku region : Recruiting: Tohoku, Japan : Contact: Yuji Kimura Clinical-trials@chugai-pharm.co.jp
Trial of Pegasys® in Patients With Chronic Hepatitis C This study is currently ... Contact: Makoto Nomura : clinical-trials@chugai-pharm.co.jp
Chugai Pharmaceutical Co., Ltd. Contact Information Chugai Pharmaceutical Co., Ltd. 1-1 Nihonbashi-Muromachi 2-chome, Chuo-ku Tokyo 103-8324, Japan
Chugai Pharma Chugai Pharmaceuticals opened their US headquarters in 2006. Starting with 9,000 sf, the client wished to provide workspace for 50 people including the US CEO ...
Chugai Pharmaceutical Co. on Friday announced its decision to accept Swiss pharmaceutical giant Roche's plan to raise its stake in the Japanese firm to 59.9 pct from the ...
For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical Co., Ltd. Corporate Communications Dept. Tel: +81-3-3273-0881
The National Kidney Foundation, Inc., a major voluntary health organization, seeks to prevent kidney and urinary tract diseases, improve the health and well-being of individuals ...
www.chugai-pharm.co.jp ... Chugai Pharmaceutical, a member of the Roche Group, is involved in biopharmaceutical ...
Selection of therapeutic antibodies successfully humanized ... Chugai Pharmaceuticals (Japan)
Website¡G www.chugai-pharm.co.jp General Manager¡G ONOMA (Chairman) , Hiroshi Yoshida (President) Established in¡G Oct . 9 .1991 Working Capital¡G NT$30,000,000
Chugai Pharmaceuticals is a research-driven, pure-play pharmaceutical company, headquartered in Japan. As a member of the Roche Group since October 2002, it has rights to develop ...
?????????????????????????????????????????????????????????? ...
Chugai Pharmaceuticals has foreign operations through subsidiaries and joint ventures with companies such as Eli Lilly. Swiss drugs group Roche owns about 60% of Chugai ...
Tarceva approved for lung cancer in Japan ... Basel, 22 October 2007 Tarceva approved for lung cancer in Japan Roche, Chugai and OSI Pharmaceuticals, Inc. announced today that ...
Chugai Pharmaceuticals is a research-driven, pure-play pharmaceutical company, headquartered in Japan. As a member of the Roche Group since October 2002, it has rights to develop ...
|
|